Silo Pharma (NASDAQ:SILO) Issues Earnings Results

Silo Pharma (NASDAQ:SILO) posted its quarterly earnings results on Friday. The company reported ($0.41) earnings per share (EPS) for the quarter, Zacks reports. Silo Pharma had a negative return on equity of 61.38% and a negative net margin of 5,255.05%.

Silo Pharma Trading Down 5.3 %

Shares of NASDAQ SILO traded down $0.07 during mid-day trading on Friday, hitting $1.25. 71,341 shares of the company traded hands, compared to its average volume of 3,195,740. The business has a 50 day moving average of $1.52 and a two-hundred day moving average of $1.24. Silo Pharma has a 1 year low of $0.77 and a 1 year high of $4.50.

Silo Pharma Company Profile

Silo Pharma Inc operates as a developmental stage biopharmaceutical company. The company is developing therapeutics that address underserved conditions, including stress-induced psychiatric disorders, chronic pain conditions, and central nervous system (CNS) diseases. It focuses on developing traditional therapies and psychedelic treatments in formulations and drug delivery systems.